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Abstract
Background:  Alcohol  is  the  most  accepted  addictive  substance  worldwide  and  its  consumption
is related  to  multiple  health,  economic,  and  social  problems.  The  liver  is  the  organ  in  charge
of ethanol  metabolism  and  it  is  susceptible  to  alcohol’s  toxic  effects.
Objetivos:  To  provide  a  detailed  review  of  the  role  of  oxidative  stress  in  alcoholic  liver  disease
and the  mechanisms  of  damage  involved,  along  with  current  information  on  the  hepatoprotec-
tive effectiveness  of  the  molecules  that  have  been  studied.
Materials  and  methods:  A  search  of  the  PubMed  database  was  conducted  using  the  following
keywords  oxidative  stress,  alcoholic  liver  damage,  alcoholic  cirrhosis,  and  antioxidants.  There
was no  time  limit  for  gathering  all  available  information  on  the  subject  at  hand.
Results: According  to  the  literature  reviewed,  oxidative  stress  plays  an  important  role  in  the
pathogenesis  of  alcoholic  liver  damage.  Molecules  such  as  reactive  oxygen  species  (ROS)  and
reactive nitrogen  species  (RNS),  formed  during  ethanol  metabolism,  structurally  and  function-
ally modify  organic  molecules.  Consequently,  biologic  processes  are  altered  and  hepatocytes
are sensitized  to  the  action  of  cytokines  like  tumor  necrosis  factor-,  as  well  as  to  the  action
of endotoxins,  activating  signaling  pathways  such  as  those  controlled  by  nuclear  factor  kappa
B, extracellular  signal  regulated  kinases,  and  mitogen  activated  protein  kinase.
Conclusions:  Oxidative  stress  plays  an  important  role  in  the  development  of  liver  damage  result-
ing from  alcohol  consumption.  The  molecules  that  have  currently  displayed  a  hepatoprotective
 Please cite this article as: Galicia-Moreno M, Gutiérrez-Reyes G. Papel del estrés oxidativo en el desarrollo de la enfermedad hepática
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effect  in  preclinical  and  clinical  trials  must  be  studied  further  so  that  their  effectiveness  can
be conﬁrmed  and  they  can  possibly  be  used  as  adjuvant  treatments  for  this  disease.
© 2014  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  All
rights reserved.
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Papel  del  estrés  oxidativo  en  el  desarrollo  de  la  enfermedad  hepática  alcohólica
Resumen
Antecedentes:  El  alcohol  es  la  sustancia  adictiva  más  aceptada  mundialmente  y  su  consumo  está
relacionado  con  múltiples  problemas  de  salud,  económicos  y  sociales.  El  hígado  es  el  órgano
encargado  del  metabolismo  del  etanol  y  es  susceptible  de  sufrir  los  efectos  tóxicos  generados
por este.
Objetivo:  Proveer  una  revisión  detallada  del  papel  del  estrés  oxidativo  en  la  enfermedad
hepática alcohólica,  los  mecanismos  de  dan˜o  involucrados,  así  como  información  actual  de
moléculas  cuya  eﬁcacia  hepatoprotectora  ha  sido  investigada.
Materiales  y  métodos:  Se  consultó  la  base  de  datos  PUBMED  utilizando  como  palabras  clave:
estrés oxidativo,  dan˜o hepático  por  alcohol,  cirrosis  alcohólica  y  antioxidantes,  sin  límite  de
tiempo para  recabar  toda  la  información  disponible  acerca  de  este  tema.
Resultados:  Conforme  a  la  literatura  consultada,  el  estrés  oxidativo  desempen˜a  un  papel  impor-
tante en  la  génesis  del  dan˜o  hepático  por  alcohol.  Moléculas  como  las  especies  reactivas  de
oxígeno (ERO)  y  las  especies  reactivas  de  nitrógeno  (ERN),  formadas  durante  el  metabolismo
del etanol,  modiﬁcan  estructural  y  funcionalmente  moléculas  orgánicas  alterando  procesos
biológicos  y  sensibilizando  a  los  hepatocitos  a  la  acción  de  citocinas  como  el  factor  de  necrosis
tumoral-, así  como  a  la  acción  de  endotoxinas,  activando  rutas  de  sen˜alización  como  las  con-
troladas por  el  factor  nuclear  kappa-B,  las  cinasas  reguladas  por  la  sen˜alización  extracelular
1/2 ERK1/2  y  las  proteína  cinasa  activada  por  mitógenos.
Conclusiones:  El  estrés  oxidativo  tiene  un  papel  importante  en  el  desarrollo  del  dan˜o  hepático
por alcohol  y  las  moléculas  que  actualmente  han  mostrado  un  efecto  hepatoprotector  en  ensayos
preclínicos  y  clínicos  necesitan  someterse  a  más  estudios  que  demuestren  su  eﬁcacia  para
considerarlos  como  tratamientos  adyuvantes  de  esta  enfermedad.
© 2014  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Todos los  derechos  reservados.
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he  most  socially  accepted  addictive  substance  worldwide
s  alcohol.  The  consumption  of  alcoholic  beverages  is  a  hall-
ark  of  social  gatherings.  However,  in  many  societies  the
onsumption  of  these  beverages  in  excess  represents  serious
ealth  and  economic  problems.1,2 Despite  this  fact,  drink-
ng  in  moderation  is  not  considered  a  health  risk.3--6 Chronic
r  excessive  alcohol  consumption  can  put  physical  and  men-
al  health  at  risk,  damaging  different  organs  such  as  the
rain,  liver,  heart,  lungs,  skeletal  musculature,  and  bones.
ts  abuse  is  also  associated  with  social  problems,  including
rafﬁc  accidents,  social  violence,  divorce,  low  productivity,
hild  abuse,  and  other  crimes.7,8
The  liver  is  the  main  site  of  ethanol  metabolism  and  the
rincipal  target  organ  of  alcohol-induced  damage.  The  sus-
eptibility  of  the  liver  to  alcohol-induced  toxicity  is  due
o  the  high  concentrations  of  alcohol  present  in  the  portal
lood,  as  well  as  to  the  metabolic  consequences  of  ethanol
etabolism.  Alcoholic  liver  disease  covers  a  spectrum  of
tages  that  includes  steatosis  (fatty  liver),  steatohepatitis,
nd  in  severe  cases,  ﬁbrosis  and/or  cirrhosis.9
T
w
cHepatic  ﬁbrosis  can  be  regarded  as  an  integrated  and
ighly  dynamic  cellular  response  to  chronic  liver  damage.10
ts  progression  is  characterized  by  the  perpetuation  of
ecrosis  of  the  parenchyma,  chronic  hepatitis,  and  qualita-
ive  and  quantitative  alterations  in  the  composition  of  the
xtracellular  matrix  (ECM),  while  the  activation  of  hepatic
tellate  cells  (HSC)  and  the  participation  of  macrophages
nd  Kupffer  cells  predominate  at  the  cellular  level.10--12 At
he  molecular  level,  growth  factors,  cytokines,  chemokines,
hanges  in  ECM  organization  and  composition,  as  well  as
xidative  stress-related  molecules,  are  seen  to  play  an
mportant  pathologic  role.10--12 The  participation  of  oxida-
ive  stress  in  almost  all  clinical  and  experimental  conditions
f  chronic  liver  disease  of  different  etiologies,  including
lcohol  consumption,  has  been  demonstrated.13--15
ethodshe  PubMed  database  was  searched  using  the  following  key-
ords  oxidative  stress,  liver  damage  from  alcohol,  alcoholic
irrhosis,  antioxidants.  There  was  no  time  limit  and  the
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Table  1  Reactive  oxygen  species  and  reactive  nitrogen
species  involved  in  alcohol-induced  hepatic  damage.
Reactive  oxygen  species  Reactive  nitrogen
species
Superoxide  radical(O2•−)
Hydroxyl  radical  (HO•)
Radical  Hydroperoxide  radical  (HO2•)
Lipid  radical  (L•)
Peroxy  lipid  radical  (LO2•)
Peroxynitryl
radical  (ONOO•)
Nitrogen  dioxide
(NO2)
Nitric  oxide  (NO)
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OHydrogen  peroxide  (H2O2)
Lipid  hydroperoxide  (LOOH)
words  AND  and  OR  were  used  as  logical  combining  terms,
enabling  us  to  limit  the  information.  The  original  and  review
articles  resulting  from  the  search  were  selected  in  accor-
dance  with  the  main  aim  of  this  study.
Free  radicals,  reactive  oxygen  species  and  reactive
nitrogen species
All  molecules  have  electrons  as  peripheral  components  and
their  behavior  determines  the  molecular  properties.  The
stability  of  a  molecule  depends  on  the  pairing  of  its  elec-
trons,  and  so  any  situation  in  which  a  species  with  an
unpaired  electron  is  produced,  could  result  in  a  poten-
tially  reactive  entity  known  as  a  free  radical.  Free  radicals
can  be  produced  in  biologic  systems  through  a  variety
of  processes.16 The  terms  free  radical  and  reactive  oxy-
gen  species  (ROS)  are  used  as  equivalents,  but  the  term
ROS  refers  to  those  chemically  reactive  molecules  derived
from  oxygen.17 ROS  include  the  superoxide  radical,  the
hydroxyl  radical,  hydrogen  peroxide,  and  hypochloric  acid.
On  the  other  hand,  the  reactive  nitrogen  species  (RNS)
refer  to  nitric  oxide  and  the  molecules  derived  from  it,
such  as  peroxynitrite  and  nitrogen  dioxide.  The  RNS  have  a
longer  half-life  than  the  ROS,  making  them  more  damaging18
(Table  1).
Different  types  of  cells  produce  ROS  in  the  liver  through
diverse  mechanisms,  after  ethanol  consumption.19 Hepa-
tocytes  use  mechanisms  such  as  CYP2E1,  mitochondrial
respiratory  chain  alterations,  and  nicotinamide  adenine  din-
ucleotide  phosphate  (NADPH)  oxidase  (Nox)  to  produce
ROS.20--22 In  cytosol,  ethanol  metabolism  by  dehydrogenase
alcohol  enables  both  the  formation  of  acetaldehyde  and
ROS23 and  the  production  of  nicotinamide  adenine  din-
ucleotide  +  hydrogen  (reduced  form)  that  can  interfere
with  electron  transference  in  the  mitochondrion,  facilitat-
ing  ROS  production.24 In  addition,  acetaldehyde  production
increases  mitochondrial  damage,  enabling  oxygen  to  be
reduced  to  superoxide.25
CYP2E1,  the  isoform  of  the  cytochrome  P450  family,  has
an  especially  high  index  of  NADPH  oxidase  activity,  allowing
the  production  of  large  quantities  of  the  superoxide  radical
and  hydrogen  peroxide.  CYP2E1  content  has  a  positive  cor-
relation  with  NADPH  oxidase  activity  and  lipid  peroxidation
in  the  hepatic  microsomes  of  alcoholic  subjects  and  rodents
fed  with  ethanol.26 An  increase  in  ROS  production  was  also
apparent  in  HepG2  cells  transfected  with  a  CYP2E1  gene.27
Thus  the  capacity  of  this  isoform  for  reducing  O2 into  the
i
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uperoxide  radical  and  hydrogen  peroxide  can  be  considered
 key  factor  contributing  to  oxidative  stress  during  chronic
xposure  to  ethanol.
Treatment  with  ethanol  has  resulted  in  Nox  activation
n  hepatocytes,  enabling  an  increase  in  superoxide  radical
roduction.28 Kupffer  cells  are  without  a  doubt  the  main
ource  of  ROS,  expressing  the  NADPH  oxidase  complex;  this
s  the  central  mechanism  for  producing  these  molecules.28,29
n  contrast,  the  HSC  are  a  small  source  of  ROS  and  these
ro-oxidant  species  participate  as  intracellular  signaling
ediators.30 Another  mechanism  involved  in  the  increase
f  ROS  during  ethanol  consumption  is  related  to  failures
n  complex  I  and  III  of  the  mitochondrial  electron  trans-
orting  chain.  Reduced  levels  of  the  sulfur-iron  centers
s  a  consequence  of  chronic  alcohol  consumption  have
een  reported.31 This  impedes  ﬂavin-semiquinone  mononu-
leotide  electron  transference  and  increases  the  production
f  superoxide  anion  within  complex  I.  These  lesions  could
ncrease  the  electron  transfer  to  the  oxygen  molecule  thus
ncreasing  the  levels  of  superoxide  anion  and  hydrogen  per-
xide  within  the  mitochondrion.30
Finally,  the  RNS  are  produced  mainly  due  to  inducible
itric  oxide  synthase  action  that  is  expressed  in  all  hepatic
ells.  Nitric  oxide  is  obtained  from  this  reaction  and  when
t  reacts  with  an  oxygen  molecule  it  facilitates  the  forma-
ion  of  the  peroxynitrite  anion,  which  can  ﬁnally  react  with
ertain  metallic  ions  or  favor  protein  S-nitrosylation.16
he  noxious  effect  of  reactive  oxygen  species  in
ipids
olyunsaturated  fats  are  essential  for  complete  cell  sys-
em  support,  including  membranes,  endoplasmic  reticulum,
nd  mitochondria.  The  alteration  of  their  structural  prop-
rties  can  have  terrible  consequences  for  cell  function.
ipid  peroxidation  has  customarily  been  the  main  effect  that
ree  radicals  have  had  on  the  lipids  that  make  up  the  cell
embranes.  As  a  result  of  this  process  many  of  the  trial
ethods  are  based  on  establishing  the  damage  induced  by
ree  radicals,  measuring  the  products  of  the  reactions  of
hese  molecules  on  the  membrane  lipids.  Some  such  prod-
cts  are  malondyaldehyde  (MDA),  4-hydroxy-2,3-nonenal
4-HNE),  and  4-hydroxy-2,3-alkenal,  whose  concentration  is
roportional  to  the  oxidative  damage  produced.32 In  1966,  Di
uzio33 was  the  ﬁrst  to  observe  lipid  peroxidation  after  expo-
ure  to  alcohol,  and  it  has  been  conﬁrmed  in  other  studies.34
ipid  peroxidation  produces  electrophiles,  such  as  MDA  or  4-
NE,  and  they  can  modify  essential  proteins.  This  results  in
he  loss  of  essential  protein  function  and  cell  homeostasis.
ncreases  in  the  products  released  through  lipid  peroxidation
ave  been  observed  in  isolated  mitochondria  of  rats  treated
ith  ethanol.34,35
oxious  effect  of  reactive  oxygen  species  in
roteins
xidative  modiﬁcations  in  proteins  can  lead  to  alterations
n  their  functions,  as  well  as  their  structure,  which  in  turn
esults  in  these  oxidized  proteins  undergoing  proteolysis.
he  oxidative  damage  in  these  molecules  is  carried  out  in  3
tages:  in  the  ﬁrst  stage,  a  protein  can  be  slightly  modiﬁed,
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ut  its  main  structure  is  intact,  resulting  in  a  slight  reduc-
ion  of  its  activity.  In  the  second  stage,  the  damage  inﬂicted
pon  the  protein  is  enough  to  cause  a  partial  unfolding  of  the
rotein  and  the  hydrophobic  sequences  that  are  generally
overed  inside  the  soluble  globular  proteins  remain  exposed
n  the  surface.  In  the  third  stage,  if  the  damaged  protein
as  not  been  identiﬁed  and  degraded  into  proteasomes,  it
orms  an  aggregate  with  other  proteins,  lipids,  and  sugars.36
There  is  little  information  on  protein  oxidation  after
thanol  consumption.  High  concentrations  of  carbonylated
roteins  in  plasma  and  erythrocytes  in  patients  with  chronic
lcoholism  have  recently  been  reported.37 Data  obtained  by
utlu-Turkoglu38 concurred  with  these  observations.
oxious effect of reactive oxygen species in
NA
OS  production  and  degradation  can  be  exogenous,  as  well
s  endogenous,  and  an  imbalance  in  these  processes  can
ause  damage  at  the  DNA  level,  which  can  lead  to  modiﬁca-
ions  of  and  severe  consequences  for  the  cell.39 Of  the  ROS,
he  hydroxyl  radical  reacts  with  DNA,  speciﬁcally  with  the
arbon  atoms  that  are  forming  double  bonds  in  the  nitroge-
ous  bases  and  abstract  a  hydrogen  from  the  methyl  group  of
hymine,  as  well  as  from  each  of  the  carbon-hydrogen  bonds
f  sugar  (2′-deoxyribose).40 Guanine  is  one  of  the  bases  with
he  greatest  propensity  for  oxidative  damage.  More  than  20
xidation  products  of  the  guanine  base  have  been  identiﬁed
nd  among  them,  the  most  abundant  and  well-studied  is  8-
xo-7,8-dihydro-desoxyguanine;  when  it  is  not  repaired  it
ecomes  mutagenic,  because  it  pairs  with  adenine  instead
f  cytosine.41
Morphologic  and  functional  abnormalities  are  one  of  the
rst  manifestations  of  ethanol-induced  damage  to  hepato-
ytes.  Different  hypotheses  have  been  formulated  to  explain
he  poor  functioning  of  this  organelle.  One  of  the  ﬁrst
ypotheses  is  linked  to  the  loss  of  DNA  integrity  and  inad-
quate  protein  synthesis.  Mitochondria  obtained  from  rats
reated  with  ethanol  showed  modiﬁcations  in  their  DNA.42
itochondrial  DNA  deletions  are  8  times  more  frequent  in
he  livers  of  alcoholic  patients  compared  with  controls.43 In
ddition,  mitochondrial  protein  synthesis  inhibition,  linked
ith  mitochondrial  DNA  damage  and  ribosomal  defects,  con-
ributes  to  diminishing  the  functionality  of  the  oxidative
hosphorylation  system,  resulting  in  an  accumulation  of  the
educed  respiratory  chain  carriers  in  the  complexes  I and  II
fter  chronic  ethanol  consumption.44--46
xidative  hepatic  damage  produced  by  ethanol
onsumption
he  capacity  of  ethanol  to  increase  levels  of  ROS  and  RNS,
ipid  peroxidation,  DNA,  and  proteins  was  demonstrated  in
 variety  of  systems,  cells,  and  species.
Initially,  alcohol  consumption  favors  an  increase  in
ntestinal  permeability  and  the  translocation  of  bacterial
ipopolysaccharide  (LPS)  from  the  intestine  to  the  liver.  In
upffer  cells,  this  LPS  interacts  with  its  receptor,  TLR4,  to
egin  the  signaling  that  favors  the  production  of  oxidative
tress  and  proinﬂammatory  cytokines,  such  as  tumor  necro-
is  factor- (TNF-), in  turn,  facilitating  liver  damage.47--50
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One  of  the  main  determinants  of  oxidative  stress  during
lcohol  consumption  is  the  induction  of  the  2E1  isoform  of
he  P450  cytochrome  family  into  the  hepatocytes  and  Kupf-
er  cells,39,51 but  not  into  the  HSC.52 CYP2E1  induction  is
esponsible  for  the  metabolism  of  ethanol  into  acetalde-
yde,  but  it  also  increases  the  vulnerability  of  alcoholics
o  the  toxicity  of  different  drugs,  industrial  solvents,  and
nesthetics.51 The  mechanisms  responsible  for  oxidative
tress  induced  by  ethanol  consumption  include  intrahepa-
ocyte  formation  of  ROS  by  the  mitochondrial  respiratory
hain,  ethanol  biotransformation,  and  the  extracellular  pro-
uction  of  ROS  by  phagocytes  (Fig.  1).53,54 The  activity
f  CYP2E1  on  ethanol,  in  particular,  enables  the  forma-
ion  of  the  hydroxyethyl  free  radicals  (HER).53 The  Kupffer
ells  and  neutrophils  inﬁltrated  in  the  liver  represent  an
mportant  source  of  oxidizing  species  and  contribute  to  caus-
ng  oxidative  stress  during  alcohol  consumption.55 At  any
ate,  the  interaction  between  oxidative  stress  and  inﬂam-
ation  for  the  progression  of  alcoholic  liver  disease  is  more
omplex.  For  example,  oxidative  damage  is  involved  in
he  sensitizing  of  hepatocytes  to  the  pro-apoptotic  action
f  the  TNF- cytokine.  In  addition,  the  ROS  produced  by
YP2E1  and  NADPH+ oxidase  activity  exacerbate  the  Kupf-
er  cell  response  to  endotoxins  by  highly  regulating  the
oll-like  4  (TLR-4)  receptor  expression.56 They  also  increase
he  transduction  of  signals  mediated  by  TLR-4  through
ranscription  factors,  such  as  the  nuclear  factor  kappa-B
NFB)  and  STAT3.  In  addition,  kinases  activated  by  extra-
ellular  signals  (ERK1/2)  and  the  mitogen-activated  protein
inase  (MAPK)  called  p38,  thus  producing  an  increase  in
he  levels  of  pro-inﬂammatory  cytokines,  such  as  TNF-
 or  IL-1, or  anti-inﬂammatory  cytokines,  such  as  IL-10
nd  IL-6.57--59 Recent  evidence  suggests  that  ethanol  sti-
ulates  the  Notch  pathway  that  is  involved  in  multiple
nﬂammatory  diseases  such  as  enterocolitis,  vasculitis,  and
ronchitis.60,61 Different  experimental  models  indicate  that
here  is  a  link  between  the  Notch1-mediated  signaling  and
FB,  which  is  a  central  regulator  of  cellular  stress  in
ll  types  of  cells  in  the  liver  and  its  activation  may  con-
ribute  to  the  development  of  alcoholic  steatohepatitis.62,63
ang  et  al.  demonstrated  that  ethanol  induces  Notch1
ignaling  in  hepatocytes  that  overexpressed  CYP2E1,  indi-
ating  that  Notch1  activation  is  dependent  on  oxidative
tress.64
The  capacity  of  ethanol  to  start  the  immune  response
as  ﬁrst  suggested  20  years  ago,  by  observing  antibodies
irected  at  protein  adducts  with  hepatic  proteins.65 Oxida-
ive  stress  has  recently  been  implicated  in  the  induced
mmunity  in  alcoholic  liver  disease  through  the  detection  of
ntibodies  that  selectively  recognize  epitopes  derived  from
he  interaction  of  the  HERs  and  hepatic  proteins.66 Anti-
ER  Ig-G  recognizes  CYP2E1  modiﬁed  by  HER  as  its  main
ntigen,  and  the  presence  of  anti-HER  antibodies  correlates
ith  CYP2E1  activity  in  both  rats  and  humans.66 However,
he  immune  response  induced  by  oxidative  stress  is  not
imited  to  the  HER  adducts;  elevated  circulating  IgG  titers
irculating  toward  epitopes  derived  from  the  modiﬁcation  of
roteins  and  ﬁnal  products  of  lipid  peroxidation,  such  as  MDA
nd  4-HNE  have  been  observed,  as  well  as  lipid  hydroperox-
des  that  are  prevalent  in  patients  with  advanced  alcoholic
iver  disease.67 Moreover,  the  combined  reaction  of  MDA
nd  acetaldehyde  with  protein  residuals  of  lysine  creates
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condensation  products  called  MDA-acetaldehyde  adducts
(MAA)  that  are  antigenic68 and  stimulate  immune  reactions
in  patients  with  alcoholic  liver  disease.69 Approximately  35%
of  the  patients  with  an  advanced  liver  disease  due  to  alco-
hol  also  show  a  response  to  T  CD4+ lymphocytes  toward
MDA-derived  antigens,  indicating  that  the  oxidative  mech-
anisms  promote  a  humoral,  as  well  as  a  cellular,  immune
response.70
Another  pathway  involved  in  hepatic  damage  caused
by  ethanol  consumption  and  oxidative  stress  is  one  that
is  modulated  by  the  adenosine-monophosphate-activated
protein  kinase  (AMPK)  in  different  cell  types,  including
neurons,  heart  cells,  skeletal  muscle  cells,  pancreatic
cells,  and  hepatic  cells.71 AMPK  has  an  important  role
in  cell  survival  during  metabolic  stress,  due  to  its  ability
to  maintain  metabolic  homeostasis.  It  also  controls  the
redox  state  and  mitochondrial  function.  It  is  known  that
the  pathways  associated  with  AMPK  can  suppress  oxidative
stress-induced  cell  death.72 This  protein  is  important  in
the  development  of  ethanol-induced  steatosis,  since  AMPK
inhibition  increases  lipogenesis  and  inhibits  fatty  acid
-oxidation.73 The  inhibition  of  AMPK  enables  acetyl-CoA
carboxylase  activation,  improving  the  levels  of  malonyl-
CoA,  which  inhibits  fatty  acid  absorption  and  -oxidation  at
the  mitochondrial  level.  In  animal  models,  AMPK  activation
by  adiponectin  and  other  agents,  such  as  rosiglitazone,
has  been  shown  to  improve  ethanol-induced  fatty  liver,
demonstrating  the  key  role  that  AMPK  protein  inhibition  has
in  the  development  of  steatosis.74,75 Nevertheless,  AMPK
inhibition  is  paradoxical  because  ethanol  metabolism  is
accompanied  by  ROS  production,  critical  factors  in  helping
control  the  AMPK  activation  mediated  by  different  stimuli
such  as  hyperglycemia  and  the  pharmacologic  treatment
with  metformin.76 These  results  suggest  that  AMPK  inhibi-
tion  due  to  alcohol  consumption  and  AMPH  activation  by
ROS  occur  through  different  mechanisms.
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ting  alcohol  consumption.
Moreover,  the  ﬁrst  studies  demonstrating  the  effects  of
xidative  stress  on  AMPK  activation  were  carried  out  more
han  10  years  ago,  when  Choi  et  al.77 showed  that  the  AMPK
ascade  was  highly  sensitive  to  ROS.
The  signaling  pathway  mediated  by  the  nuclear  factor-
rythroid  2-related  factor-2  (Nrf2)-ARE  also  plays  an
mportant  role  in  the  development  of  alcoholic  liver
isease.  The  induction  of  many  cytoprotective  enzymes
n  response  to  chemical  stress  is  primarily  regulated
t  the  transcriptional  level  by  a  protein  called  ARE  (a
is-regulating  element)  that  initially  was  found  in  the
romoter  genes  that  encode  for  2  important  detoxify-
ng  enzymes:  glutathione  S-transferase  and  NADPH:quinone
xidoreductase.78 Gene  transcription  activation  through  ARE
s  mediated  by  Nrf2.  There  is  evidence  that  the  levels
f  the  protein,  as  well  as  the  mRNA  of  Nrf2,  are  ele-
ated  in  hepatic  tissue  and  in  the  hepatocytes  of  animals
hronically  treated  with  ethanol.  HepG2  cells  overex-
ressed  the  CYP2E1  isoform  and  also  showed  an  increase
n  mRNA  and  Nrf2  protein  expression  compared  with  con-
rol  HepG2  cells.79 Other  reports  attribute  an  important
ole  to  Nrf2  in  the  protection  against  ethanol-induced
epatic  damage.  Nrf2  knockout  mice  that  were  chroni-
ally  given  ethanol  were  observed  to  have  a  signiﬁcantly
igher  mortality  rate  than  wild  type  animals;80 a  diminished
bility  to  detoxify  acetaldehyde  was  also  observed  in  the
nock-out  mice,  which  enabled  the  accumulation  of  toxic
etabolites.80
Despite  the  difﬁculty  of  experimentally  reproducing  a
tate  of  alcoholic  ﬁbrosis  in  animal  models,  different  studies
ave  shown  that  lipid  peroxidation  precedes  the  initiating
ignals  of  ﬁbrosis  and  is  associated  with  an  increase  in  proﬁ-
rogenic  cytokine  production,  such  as  transforming  growth
actor    (TGF-).81 It  has  also  been  reported  that  lipid  per-
xidation  induced  by  ethanol  consumption  promotes  NFB
ransactivation,  thus  favoring  2  (1)  collagen  promoter  gene
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Figure  2  Signaling  pathways  activated  by  the  ROS  generated  during  ethanol  consumption.  ROS  that  are  produced  extracellularly
have the  capacity  to  promote  TLR-4  overexpression,  favoring  the  pathway  of  damage  mediated  by  LPS.  This  leads  to  the  transloca-
tion of  the  NFB transcription  factor  to  the  nucleus  and  thus  proinﬂammatory  cytokine  gene  transcription  takes  place.  Intracellular
ROS can  also  favor  NFB  activation  through  the  NFB/Notch1  complex,  which  increases  the  damage.
In regard  to  the  cytoplasm,  ROS  generated  from  different  sources,  such  as  oxidase  NADPH  activity,  activate  different  proteins
related to  hepatic  damage  such  as  ERK1/2,  p38,  and  JAK,  which  promote  the  activation  of  transcription  factors  such  as  AP1  and
STAT3, positively  modulating  pro  and  anti-inﬂammatory  cytokine  gene  expression,  respectively.
The cell  signaling  related  to  the  hepatoprotective  response  is  also  altered  by  ROS;  the  pathways  induced  by  AMPK  and  Nrf2/ARE  are
inhibited by  the  action  of  the  oxidizing  species.
The  green  arrows  indicate  response  promotion  and  the  red  arrows  indicate  response  inhibition.
AMPK: adenosine  monophosphate-activated  protein  kinase;  ARE:  antioxidant  response  element;  ERK1/2:  extracellular  signal-
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xpression  in  the  HSC  through  the  stimulation  of  the  kinase
ascade,  in  which  PKC,  PI3K,  and  PKB/Akt  participate.82
hese  observations  are  consistent  with  the  role  of  4-HNE
hat  acts  as  a  proﬁbrogenic  stimulus  for  collagen  production
n  human  HSCs.83
A  summary  of  these  signaling  pathways  is  illustrated  in
igure  2.
Given  that  multiple  factors  are  involved  in  the  production
f  oxidative  stress  during  alcoholic  liver  disease,  sex  and
diosyncrasy  are  points  that  should  be  taken  into  account.
Women  develop  a  more  severe  form  of  alcoholic  liver  dis-
ase  with  less  consumption  and  fewer  years  of  exposure  to
his  hepatotoxin.  The  exact  mechanisms  are  unknown,  but
here  is  evidence  suggesting  that  the  sex  hormones  play  an
mportant  part.84 Women  with  chronic  alcoholism  have  men-
trual  cycle  disorders  that  include  amenorrhea,  anovulation,
t
g
s
iB:  nuclear  factor  B;  Nrf2:  nuclear  factor  erythroid  2-related
r  irregular  cycles  and  luteal  phase  dysfunction.85,86 Stud-
es  carried  out  on  rats  have  shown  that  alcohol  ingestion
onditions  low  levels  of  estrogen  and  anovulatory  cycles
haracterized  by  a  decrease  in  progesterone.87 Similar
esponses  have  been  observed  in  premenopausal  alcoholic
omen.  These  results  suggest  that  estrogens  (and  pro-
esterone)  are  important  in  the  development  of  alcoholic
iver  disease  and  the  hormonal  impact  can  be  different
epending  on  the  stage  of  life  of  the  woman  (menopause,
ostmenopause),  with  alcohol  ingestion  having  an  important
ole  in  producing  damage.
On  the  other  hand,  all  the  phases  that  participate  in
he  development  of  alcoholic  liver  disease  are  regulated  by
enes,  that  either  by  themselves  or  in  combination,  repre-
ent  risks  and  inﬂuence  the  reactions  with  ethanol.88 After
ts  absorption,  ethanol  is  degraded  in  the  liver  and  other
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tissues  by  the  alcohol  dehydrogenase  (ADH)  enzyme  in  the
cytosol  and  by  CYP2E1  in  the  microsomes.  There  are  dif-
ferent  kinds  of  ADH  and  2  of  the  known  human  ADH  genes
are  the  polymorphic  ADH2  and  ADH3,  with  3  existing  alleles
each,  and  they  reveal  important  enzymatic  characteristics.
The  alleles  for  ADH2  are  ADH2*1,  found  in  Caucasians,  and
ADH2*2,  found  in  Asians.  According  to  the  differences  in  the
capacity  for  metabolizing  alcohol  into  acetaldehyde,  it  has
been  speculated  that  individuals  with  the  ADH2*2  allele  are
at  greater  risk  for  developing  hepatic  damage  due  to  higher
acetaldehyde  exposure.89 There  is  a  similar  situation  with
the  genetic  variants  of  CYP2E1;  the  mutant  CYP2E1  c2  allele
is  associated  with  greater  gene  transcription,  protein  level,
and  enzyme  activity  than  the  c1  allele,  which  can  result  in
greater  exposure  of  the  liver  to  acetaldehyde  and  the  ROS,
exacerbating  hepatic  damage.88
Antioxidant  defenses  in  alcoholic  liver  disease
During  ethanol  consumption  different  pathways  are  acti-
vated  that  lead  to  ROS  overproduction.  However,  such
massive  production  often  surpasses  the  capacity  of  the  endo-
genic  antioxidant  defenses  to  counteract  the  generated
damage  and  this  phenomenon  is  known  as  oxidative  stress.
The  organism  has  multiple  mechanisms  for  confronting
this  phenomenon.  The  antioxidant  defense  system  is  made
up  of  a  group  of  substances  that  delay  or  prevent  oxidation
of  an  oxidizable  substrate,  such  as  carbohydrates,  proteins,
lipids,  and  DNA  molecules.90
It  is  known  that  the  administration  of  antioxidant  agents,
or  iron,  zinc,  and  copper  chelating  agents,  as  well  as
agents  that  replace  reduced  glutathione  (GSH),  such  as
N-acetyl  cysteine,  can  attenuate  or  prevent  the  toxic
effects  of  alcohol.91 Polyunsaturated  lipids  (necessary  in
order  for  lipid  peroxidation  to  take  place)  replaced  by
medium-chain  triglycerides  or  saturated  lipids,  adminis-
tered  intragastrically  in  the  diet  of  rats,  prevents  or  reduces
lipid  peroxidation  and  the  hepatic  damage  induced  by  alco-
hol  consumption.92,93 Interestingly,  the  administration  of
antioxidants  such  as  ebselen,  vitamin  E,  superoxide  dismu-
tase,  and  GSH  precursors  prevents  alcohol-induced  hepatic
damage  in  rats.94
Other  compounds  that  have  shown  beneﬁcial  responses  to
ethanol  consumption-induced  hepatic  damage  are  the  cor-
ticosteroids.  This  group  of  drugs  can  attenuate  the
inﬂammatory  response  during  alcoholic  hepatitis,  reduce
cytokine  production,  suppress  acetaldehyde  adduct  for-
mation,  and  inhibit  collagen  production.95 Patients  with
severe  alcoholic  liver  disease  that  have  been  treated  with
steroids  have  been  observed  to  show  short-term  histo-
logic  improvement;  this  improvement  is  associated  with  a
decrease  in  TNF- circulation  and  in  intercellular-1  adhesion
molecule  expression,  as  well  as  with  changes  in  the  soluble
intercellular-1  adhesion  molecule  in  the  hepatic  vein.96
Without  a  doubt,  the  plant  that  has  been  studied  the
most  in  relation  to  the  treatment  of  liver  diseases  is  Silybum
marianum.  It  is  made  up  of  4  isomers:  silibinin,  isosili-
binin,  silidianin,  and  silicristin.  Of  the  4,  silibinin  is  the
most  active  compound.  According  to  the  results  of  different
experimental  studies  on  hepatic  damage,  silymarin  offers
adequate  protection  exerting  good  antioxidant  effects97
and  antiﬁbrotic  effects,98 in  addition  to  being  an  excellent
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mmunomodulator  and  cell  membrane  stabilizer,  as  well  as
iding  in  the  process  of  regeneration.98--101 Clinically,  sily-
arin  has  demonstrated  positive  effects  on  alcoholic  liver
isease,  hepatic  cirrhosis,  drug-induced  hepatic  damage,
nd  in  diabetic  patients.101
Metadoxine  (pyridoxol  L-2-pyrrolidone-5-carboxylate),
he  ionic  pair  between  pyrrolidone  carboxylate  and  pyri-
oxine,  is  another  of  the  compounds  that  has  demonstrated
reat  efﬁcacy  in  the  treatment  of  acute  alcohol  intoxi-
ation.  Pyrrolidone  carboxylate  participates  in  amino  acid
etabolism  through  the  glutathione  pathway.102 It  partici-
ates  in  de  novo  ATP  synthesis103 and  prevents  the  reduction
f  ATP  levels  in  the  brain  and  liver  of  rats  with  acute  ethanol
ntoxication.104 Importantly,  it  is  known  that  pyridoxine
ncreases  the  metabolic  degradation  rate  of  ethanol,  as
ell  as  the  cell  function  damage  caused  by  acetaldehyde.105
etadoxine  appears  to  be  capable  of  accelerating  ethanol
etabolism  in  both  rats  and  humans  through  facilitat-
ng  increased  activity  of  the  dehydrogenase  acetaldehyde
nzyme,  increasing  the  plasma  clearing  of  ethanol  and
cetaldehyde,  and  the  renal  elimination  of  ketones  that  are
 product  of  its  metabolism.106--108 This  compound  has  been
apable  of  preventing  GSH  depletion,  oxidative  damage  at
he  lipid  level,  the  accumulation  of  collagen,  and  alcohol
nd  acetaldehyde-induced  TNF- secretion  in  hepatocytes
nd  stellate  cells.109
Furthermore,  metadoxine  has  shown  beneﬁcial  effects  in
elation  to  early  mortality  in  patients  with  alcoholic  hepati-
is  at  the  Hospital  General  de  México  (Higuera  de  la  Tijera,
npublished  data).
It  is  our  opinion  that  the  abovementioned  compounds  are
he  outstanding  elements  in  the  treatment  of  alcoholic  liver
nd  the  efﬁcacy  of  many  of  them  has  been  demonstrated
n  animal  models.  Such  results  encourage  the  further  study
f  these  molecules,  but  through  controlled  clinical  studies,
o  that  in  the  future  they  may  be  considered  a tool  in  the
harmacologic  treatment  of  this  disease.
onclusions
hronic  ethanol  consumption  plays  a  relevant  role  in  the
eneration  of  hepatic  disease.  Considering  that  normal  ROS
iosynthesis  is  a  natural  part  of  biochemical  processes,
thanol  ingestion  is  thought  to  favor  oxidative  stress  and
he  promotion  of  inﬂammatory  and  ﬁbrotic  damage.  Because
here  are  multiple  mechanisms  through  which  alcohol  facil-
tates  hepatic  damage,  the  development  of  therapeutic
trategies  for  treating  this  disease  is  very  complex,  which
xplains  the  continuing  lack  of  effective  treatment  for
esolving  this  health  problem.  However,  we  believe  that  by
locking  one  of  the  pathways  of  damage  through  the  use
f  antioxidants,  supplements  favoring  de  novo  GSH  gener-
tion,  polyphenolic  agents,  such  as  vitamin  E  or  silymarin,
nd  drugs,  such  as  metadoxine,  could  improve  the  quality
f  life  of  these  patients.
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